Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation

Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation

Background: Dual antiplatelet treatment (DAPLT) for at least 12 months is recommended after drug eluting stent (DES) implantation, but concerns regarding the extended use of this treatment persist due to increased risk of bleeding. In this study are assessed the incidence, correlates, and clinical s...

Full description

Bibliographic Details
Main Authors: Vassilis Voudris, Panagiotis Karyofyllis, Constantinos Doulaptsis, Ioannis Moukas, Sofia Thomopoulou, Denis V. Cokkinos
Format: Article
Language:English
Published: Elsevier 2014-12-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Coronary artery disease
Bleeding
Drug eluting stents
Diabetes mellitus
Antiplatelet therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906714000748

Similar Items

Similar Items